Summary
In order to determine the frequencies of apolipoproteins (apo) E5 and E7 and their relation to plasma lipid levels, apo E phenotypes were determined in 608 healthy Japanese male adults by two-dimensional gel electrophoresis. Apo E5 and E7 were observed in 2.8% of the subjects, in addition to the three common apo E isoforms, E2, E3, and E4. Apo E5 was divided into two subtypes based on the migration rate on SDS/PAGE, E5f is the type with faster migration and E5s slower migration. The gene frequencies were: the ε3 allele, 0.841; the ε4 allele, 0.095; the ε2 allele, 0.049; the ε7 allele, 0.009; the ε5 allele encoding apo E5f (the ε5f allele), 0.004; and the ε5 allele encoding apo E5s (the ε5s allele), 0.001. The five individuals with apo E5f and the eleven with apo E7 were heterozygotes and normocholesterolemic. Also plasma apo B and apo E levels were not increased in any subjects with apo E5f or apo E7. The data suggests that apo E5f and E7 are not rare in the Japanese population but that neither apo E5f nor E7 are associated with hypercholesterolemia in most of the heterozygotes.
Similar content being viewed by others
Article PDF
References
Boerwinkle E, Utermann G (1988): Simultaneous effects of apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet42: 104–112
Bouthillier D, Sing CF, Davignon J (1983): Apolipoprotein E phenotyping with a single method: application to the study of informative matings. J Lipid Res24: 1060–1069
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993): Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science261: 921–923
Dong L-M, Yamamura Y, Yamamoto A (1990): Enhanced binding activity of an apolipoprotein E mutant, apo E5, to LDL receptors on human fibroblasts. Biochem Biophys Res Commun168: 409–414
Eto M, Watanabe K, Ishii K (1985): A rapid flat gel isoelectric focusing method for the determination of apolipoprotein E phenotypes and its application. Clin Chem Acta149: 21–28
Eto M, Watanabe K, Ishii K (1986): A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations. Clin Genet30: 422–427
Ehnholm C, Mahley RW, Chappell DA, Weisgraber KH, Ludwig E, Witztum JL (1984): Role of apolipoprotein E in the lipolytic conversion of B-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc Natl Acad Sci USA81: 5566–5570
Friedewald WT, Levy RI, Fredrickson DS (1972): Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem18: 499–502
Ghiselli G, Schaefer EJ, Gascon P, Brewer HB Jr (1981): Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science214: 1239–1241
Gregg RE, Zech LA, Schaefer EJ, Brewer HB Jr (1981): Type III hyperlipoproteinemia: Defective metabolism of an abnormal apolipoprotein E. Science211: 584–586
Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brewer HB Jr (1986): Abnormalin vivo metabolism of apolipoprotein E4 in humans. J Clin Invest78: 815–821
Hamaguchi H, Yamada M, Shibasaki M, Mukai M, Yabe T, Kondo I (1982): Genetic analysis of human lymphocyte proteins by two-dimensional gel electrophoresis: 3. Frequent occurrence of genetic variants in some abundant polypeptides of PHA-stimulated peripheral blood lymphocytes. Hum Genet62: 142–147
Hamaguchi H, Watanabe Y, Yamanouchi Y, Yanagi H, Arinami T, Miyazaki R, Tsuchiya S, Kobayashi K (1992): Analysis of genes associated with hypercholesterolemia in the Japanese population. In: Roberts DF, Fujiki N, Torizuka K (eds). Isolation, migration and health. Cambridge University Press, New York, pp 154–166
Maeda H, Nakamura H, Kobori S, Okada M, Mori H, Niki H, Ogura T, Hiraga S (1989a): Identification of human apolipoprotein E variant gene: Apolipoprotein E7 (Glu244,245→Lys244,245)1. J Biochem105: 51–54
Maeda H, Nakamura H, Kobori S, Okada M, Niki H, Ogura T, Hiraga S (1989b): Molecular cloning of a human apolipoprotein E variant: E5(Glu3→Lys3)1. J Biochem105: 491–493
Mahley RW (1988): Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science240: 622–630
Mailly F, Xu C, Xhignesse M, Lussier-Cacan S, Talmud PJ, Davignon J, Humphries SE, Nestruchk AC (1991): Characterization of a new apolipoprotein E5 variant detected in two French-Canadian subjects. J Lipid Res32: 613–620
Menzel HJ, Kladetzky RG, Assmann G (1983): Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis3: 310–315
Merril CR, Goldman D, Sedman SA, Ebert MH (1981): Ultrasensitive stain for proteins in polyacrylamide gels show regional variation in cerebrospinal fluid proteins. Science211: 1437–1438
Noguchi S, Murakami K, Yamada N (1993): Apolipoprotein E genotype and Alzheimer's disease. Lancet342: 737
Noma A, Okabe H, Netsu-Nakayama K, Ueno Y, Shinohara H (1979): Improved method for simultaneous determination of cholesterol in high-and low-density lipoproteins. Clin Chem25: 1480–1481
O'Farrell PH (1975): High resolution two-dimensional electrophoresis of proteins. J Biol Chem250: 4007–4021
Ordovas JM, Litwack-Klein L, Wilson PWF, Schasefer MM, Schaefer EJ (1987): Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apo E1 and apo E5 isoforms. J Lipid Res28: 371–380
Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993): Apolipoprotein E polymorphism and Alzheimer's disease. Lancet342: 697–699
Rall SC Jr, Weisgraber KH, Innerarity TL, Mahley RW (1982): Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci USA79: 4694–4700
Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH St, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993): Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology43: 1467–1472
Sing CE, Davignon J (1985): Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet37: 268–285
Smit M, de Knijff P, Rosseneu M, Bury J, Klasen E, Frants R, Havekes L (1988): Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum Genet80: 287–292
Tajima S, Yamamura T, Yamamoto A (1988): Analysis of apolipoprotein E5 gene from a patient with hyperlipoproteinemia. J Biochem104: 48–52
Tajima S, Yamamura T, Menju M, Yamamoto A (1989): Analysis of apolipoprotein E7 (apolipoprotein E-Suita) gene from a patient with hyperlipoproteinemia. J Biochem105: 249–253
Towbin H, Staehelin T, Gordon J (1979): Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA76: 4350–4354
Tsuchiya S, Yamanouchi Y, Onuki M, Yamakawa K, Miyazaki R, Taya T, Kondo I, Ohnuki M, Hamaguchi H (1985): Frequencies of apolipoprotein E5 and E7 in apparently healthy Japanese. Jpn J Human Genet30: 271–278
Utermann G, Hees M, Steinmetz A (1977): Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature269: 604–607
Utermann G, Pruin N, Steinmetz A (1979): Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet15: 63–72
Utermann G, Hardewig A, Zimmer F (1984): Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet56: 237–241
Utermann G (1987): Apolipoprotein E polymorphism in health and disease. Am Heart J113: 433–440
Wardell MR, Suchlking PA, Janus ED (1982): Genetic variation in human apolipoprotein E. J Lipid Res23: 1174–1182
Wardell MR, Rall SC Jr, Schaefer EJ, Kane JP, Weisgraber KH (1991): Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity. J Lipid Res32: 521–528
Weisgraber KH, Innerarity TL, Mahley RW (1982): Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cystein-arginine interchange at a single site. J Biol Chem257: 2518–2521
Yamamura Y, Tamamoto A, Hiramori K, Nambu S (1984a): A new isoform of apolipoprotein E-apo E5-associated with hyperlipidemia and atherosclerosis. Atherosclerosis50: 159–172
Yamamura T, Yamamoto A, Sumiyoshi T, Hiramori K, Nishioeda Y, Nambu S (1984b): New mutants of apolipoprotein E associated with atherosclerotic disease but not to type III hyperlipoproteinemia. J Clin Invest74: 1229–1237
Yanagi H, Shimakura Y, Yamanouchi Y, Watanabe Y, Tsuchiya S, Hamaguchi H (1990): Association of hypercholesterolemia and apolipoprotein E4 in school children. Clin Genet38: 264–269
Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, Arinami T, Oguni E, Mizusawa H, Shoji S, Hamaguchi H (1994): Dose-dependent association of apolipoprotein E allele ε4 with lateonset sporadic Alzheimer's disease. Ann Neurol (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamanouchi, Y., Arinami, T., Tsuchiya, S. et al. Apolipoprotein E5 and E7 in apparently healthy Japanese males: Frequencies and relation to plasma lipid levels. Jap J Human Genet 39, 315–325 (1994). https://doi.org/10.1007/BF01874050
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01874050